NC
RETA

NinePointTwo Capital’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

NinePointTwo Capital’s Portfolio RETA Stock Details RETA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$292K Buy
2022
Q1 		– Sell
2021
Q4 		$284K Buy